Physician profile
Kevin Davidson
NPI 1356571392
$18,684.62
in general payments reported to CMS, 2019-2025
16 companies · $11K in 2025
The $11K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.80 · 2020: $15.92 · 2021: $62.73 · 2022: $2,332 · 2023: $4,014 · 2024: $936 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Consulting Fee: $5,900 · Food and Beverage: $2,051 · Travel and Lodging: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Consulting Fee | $5,900.00 |
| Food and Beverage | $2,051.07 |
| Travel and Lodging | $1,254.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,745.60 | 2022-2025 | Ion, Da Vinci Surgical System |
| US Endoscopy | $4,000.00 | 2025 | |
| Siemens Medical Solutions USA, INC. | $2,487.01 | 2023-2025 | Cios Spin |
| Pulmonx Corporation | $1,207.33 | 2022-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Partner Therapeutics, INC. | $400.00 | 2024 | Leukine |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.49 | 2019-2022 | |
| Boston Scientific Corporation | $169.96 | 2023 | Exalt Model D, Hydratome Rx 44 |
| Steris Corporation | $150.12 | 2025 | |
| Galvanize Therapeutics, INC | $137.15 | 2024 | Aliya System |
| Ambu INC. | $58.47 | 2025 | |
| Abiomed | $58.02 | 2024 | Impella |
| Veran Medical Technologies, INC. | $28.08 | 2020-2021 | |
| Glaxosmithkline, LLC. | $21.62 | 2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $21.39 | 2023 | Fasenra |
| Philips North America LLC | $12.38 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $10.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.